Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Net Cash Flow Growth (3y) (2020 - 2026)

Analysis

Catheter Precision (VTAK) Net Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -9.45%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -16.59%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -0.80%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 60.16%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -85.83%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 43.26%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 1.60%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -26.30%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 269.22%
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 26.70%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.70%
Mar 31, 2026 27.97%
Dec 31, 2025 -34.68%
Sep 30, 2025 -55.62%
Jun 30, 2025 27.23%
Mar 31, 2025 -43.08%
Dec 31, 2024 31.77%
Sep 30, 2024 46.77%
Jun 30, 2024 -32.87%
Mar 31, 2024 36.11%
Dec 31, 2023 40.87%
Sep 30, 2023 -34.43%
Jun 30, 2023 -34.61%
Mar 31, 2023 -43.34%
Dec 31, 2022 212.72%
Sep 30, 2022 -2.46%
Jun 30, 2022 46.81%
Mar 31, 2022 31.69%
Dec 31, 2021 -27.93%
Sep 30, 2021 27.68%